bovine endothelial cell growth 27 medium (Cell Applications Inc)
Cell Applications Inc is a verified supplier 
Cell Applications Inc manufactures this product 
96
Structured Review
Cell Applications Inc
bovine endothelial cell growth 27 medium
Bovine Endothelial Cell Growth 27 Medium, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 96/100, based on 393 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bovine+endothelial+cell+growth+27+medium/Major+Media/10__21203_slash_rs__3__rs___91978_slash_v1-227-138-144
Average 96 stars, based on 393 article reviews
Bovine Endothelial Cell Growth 27 Medium, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 96/100, based on 393 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bovine+endothelial+cell+growth+27+medium/Major+Media/10__21203_slash_rs__3__rs___91978_slash_v1-227-138-144
Average 96 stars, based on 393 article reviews
bovine endothelial cell growth 27 medium - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
Concentration Assay:Article Title: Engineered Whole Cut Meats Assembled of Cell Fibers Constructed by Tendon-Gel Integrated Bioprinting Article Snippet: .. The medium 18 was then switched for DMEM with 10% FBS containing different adipogenic components to compare: 19 Rosiglitazone (at 20 μM final concentration, Sigma Aldrich, R2408), Insulin (at 10 μg/mL final concentration, 20 Sigma Aldrich, I6634), Troglitazone (at 40μM final concentration, Sigma Aldrich, T2573), Pristanic acid (at 50 21 μM final concentration, Funakoshi, 11-1500), Phytanic acid (at 50 μM final concentration, Sigma Aldrich, P4060), 22 Erucic acid (at 50 μM final concentration, Sigma Aldrich, 45629-F), Elaidic acid (at 50 μM final concentration, 23 Sigma Aldrich, 45089), Oleic acid (at 50μM final concentration, Sigma Aldrich, O1383), Palmitoleic acid (at 50 24 μM final concentration, Sigma Aldrich, 76169), Myristoleic acid (at 50 μM final concentration, Sigma Aldrich, 25 41788), TGF type I receptor activin-like kinase 5 inhibitor (ALK5i II, 2-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-26 yl]-1,5-naphthyridine, at 1-10 μM final concentration, Cayman, 14794) or Article Title: Engineered Whole Cut Meats Assembled of Cell Fibers Constructed by Tendon-Gel Integrated Bioprinting Article Snippet: .. The medium 18 was then switched for DMEM with 10% FBS containing different adipogenic components to compare: 19 Rosiglitazone (at 20 μM final concentration, Sigma Aldrich, R2408), Insulin (at 10 μg/mL final concentration, 20 Sigma Aldrich, I6634), Troglitazone (at 40μM final concentration, Sigma Aldrich, T2573), Pristanic acid (at 50 21 μM final concentration, Funakoshi, 11-1500), Phytanic acid (at 50 μM final concentration, Sigma Aldrich, P4060), 22 Erucic acid (at 50 μM final concentration, Sigma Aldrich, 45629-F), Elaidic acid (at 50 μM final concentration, 23 Sigma Aldrich, 45089), Oleic acid (at 50μM final concentration, Sigma Aldrich, O1383), Palmitoleic acid (at 50 24 μM final concentration, Sigma Aldrich, 76169), Myristoleic acid (at 50 μM final concentration, Sigma Aldrich, 25 41788), TGF type I receptor activin-like kinase 5 inhibitor (ALK5i II, 2-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-26 yl]-1,5-naphthyridine, at 1-10 μM final concentration, Cayman, 14794) or |